Open-label, single-arm, multi-center validation study of the ROSA-Scale (Relevant Outcome Scale for Alzheimer Patients) in patients with dementia of Alzheimer's type (DAT) treated with memantine over a 3 months period
Latest Information Update: 23 Dec 2012
At a glance
- Drugs Memantine (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- Sponsors Merz Pharmaceuticals GmbH
- 23 Dec 2012 New trial record